Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,396Revenue $M596Net Margin (%)7.2Altman Z-Score3.4
Enterprise Value $M3,651EPS $0.8Operating Margin %11.9Piotroski F-Score7
P/E(ttm)75.6Beneish M-Score-1.8Pre-tax Margin (%)11.5Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales5.45-y EBITDA Growth Rate %-2.4Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow88.5y-y EBITDA Growth Rate %216ROA % (ttm)3.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)5.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M71.7ROIC % (ttm)7.8Gross Margin Increase y-yY

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLGeorge Soros 2015-03-31 Buy 0.03%$30.2 - $47.3
($39.79)
$ 47.7720%New holding61,206
IPXLJoel Greenblatt 2015-03-31 Sold Out -0.02%$30.2 - $47.3
($39.79)
$ 47.7720%Sold Out0
IPXLNWQ Managers 2015-03-31 Add0.02%$30.2 - $47.3
($39.79)
$ 47.7720%Add 3.32%936,127
IPXLMario Gabelli 2015-03-31 Sold Out -0.0011%$30.2 - $47.3
($39.79)
$ 47.7720%Sold Out0
IPXLNWQ Managers 2014-12-31 Reduce-0.1%$23.63 - $32.75
($29.3)
$ 47.7763%Reduce 30.25%906,043
IPXLJoel Greenblatt 2014-12-31 Add0.01%$23.63 - $32.75
($29.4)
$ 47.7762%Add 136.17%79,609
IPXLMario Gabelli 2014-12-31 Buy $23.63 - $32.75
($29.3)
$ 47.7763%New holding6,775
IPXLNWQ Managers 2014-09-30 Add0.08%$22.77 - $30.68
($25.55)
$ 47.7787%Add 31.90%1,298,995
IPXLJoel Greenblatt 2014-09-30 Buy 0.01%$22.77 - $30.68
($25.55)
$ 47.7787%New holding33,709
IPXLNWQ Managers 2014-06-30 Buy 0.3%$23.6 - $30.68
($26.93)
$ 47.7777%New holding984,841
IPXLJoel Greenblatt 2012-03-31 Sold Out -0.05%$18.64 - $24.37
($20.72)
$ 47.77131%Sold Out0
IPXLJoel Greenblatt 2011-12-31 Reduce-0.47%$16.53 - $20.75
($18.65)
$ 47.77156%Reduce 88.51%21,057
IPXLJoel Greenblatt 2011-09-30 Reduce-0.38%$15.26 - $21.56
($19.54)
$ 47.77144%Reduce 40.22%183,187
IPXLJoel Greenblatt 2011-06-30 Add0.76%$20.21 - $28.73
($25.28)
$ 47.7789%Add 446.09%306,452
IPXLGeorge Soros 2011-06-30 Sold Out $20.21 - $28.73
($25.28)
$ 47.7789%Sold Out0
IPXLJoel Greenblatt 2011-03-31 Reduce-1.55%$20.11 - $25.52
($22.84)
$ 47.77109%Reduce 78.32%56,118
IPXLGeorge Soros 2011-03-31 Reduce$20.11 - $25.52
($22.84)
$ 47.77109%Reduce 41.13%13,600
IPXLJoel Greenblatt 2010-12-31 Buy 1.7%$17.91 - $21.86
($19.9)
$ 47.77140%New holding258,801
IPXLGeorge Soros 2010-12-31 Buy 0.01%$17.91 - $21.86
($19.9)
$ 47.77140%New holding23,100
IPXLGeorge Soros 2010-06-30 Sold Out $16.66 - $21.62
($19.29)
$ 47.77148%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HSU LARRYDirector 2014-06-06Sell100,000$28.3868.32view
TERRERI PETER RDirector 2014-05-27Sell3,000$2870.61view
HSU LARRYDirector 2014-05-22Sell50,000$27.2275.5view
HSU LARRYDirector 2014-05-21Sell3,800$26.5380.06view
TERRERI PETER RDirector 2014-05-20Sell666$26.0783.24view
TERRERI PETER RDirector 2014-05-19Sell950$26.0383.52view
FLEMING NIGELDirector 2014-05-16Sell1,900$25.7285.73view
TERRERI PETER RDirector 2014-05-13Sell666$26.778.91view
FLEMING NIGELDirector 2014-05-12Sell1,333$26.5879.72view
MARKBREITER MICHAELDirector 2014-05-08Sell12,500$26.4480.67view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 
Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
comment on IPXL Sep 24 2012 
President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 
Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 5,000 Shares Aug 12 2010 
Impax Laboratories Inc. (IPXL) CEO Larry Hsu buys 10,000 Shares Aug 12 2010 
Impax Laboratories Reports Second Quarter 2009 Financial Results Aug 04 2009 

More From Other Websites
Impax to Report Second Quarter 2015 Results on August 10, 2015 Jul 06 2015
Impax to Report Second Quarter 2015 Results on August 10, 2015 Jul 06 2015
Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors Jul 06 2015
Impax Announces Resignation of Larry Hsu, Ph.D. from Board of Directors Jul 06 2015
IMPAX LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination... Jun 30 2015
Alan Fournier Sells Stake in Gilead Sciences Jun 25 2015
IMPAX LABORATORIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 25 2015
Impax Laboratories, Inc. Prices Private Offering of Convertible Senior Notes Jun 25 2015
Impax Laboratories, Inc. Prices Private Offering of Convertible Senior Notes Jun 25 2015
Keep An Eye On These 10 After-Hours Movers Jun 25 2015
IMPAX LABORATORIES INC Files SEC form 8-K, Regulation FD Disclosure, Other Events Jun 24 2015
Impax Laboratories, Inc. Announces Private Offering of Convertible Senior Notes Jun 24 2015
Impax Laboratories, Inc. Announces Private Offering of Convertible Senior Notes Jun 24 2015
Impax's Zomig Nasal Spray Gets FDA Nod for Pediatrics - Analyst Blog Jun 17 2015
FDA Approves ZOMIG® (zolmitriptan) Nasal Spray for Migraine in Pediatric Patients (Ages 12-17) Jun 16 2015
Edited Transcript of IPXL presentation 11-Jun-15 4:20pm GMT Jun 12 2015
Impax to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Jun 04 2015
Impax to Present at the Goldman Sachs 36th Annual Global Healthcare Conference Jun 04 2015
Coverage initiated on Impax Labs by Raymond James Jun 03 2015
Momentum players have a full menu to choose from Jun 02 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK